Passage Bio, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
LYNX1 CAPITAL MANAGEMENT LP | 02/14/2025 | 9.26 M | $5.25 M | 9.85% | 14.99% |
ORBIMED ADVISORS LLC | 02/14/2025 | 7.40 M | $4.20 M | -24.62% | 11.99% |
VESTAL POINT CAPITAL, LP | 02/14/2025 | 6.10 M | $3.46 M | 0.00% | 9.88% |
NEW LEAF VENTURE PARTNERS, L.L.C. | 02/13/2025 | 2.50 M | $1.42 M | 0.00% | 4.04% |
02/10/2025 | 2.46 M | $1.63 M | 0.00% | 3.98% | |
VANGUARD GROUP INC | 02/11/2025 | 2.07 M | $1.17 M | 0.00% | 3.35% |
TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.50 M | $850.65 K | 0.00% | 2.43% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 1.38 M | $783.44 K | -0.82% | 2.24% |
ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 942.90 K | $533.00 K | -1.91% | 1.53% |
MORGAN STANLEY | 02/14/2025 | 812.44 K | $460.74 K | 5,944.06% | 1.32% |
BLACKROCK, INC. | 02/07/2025 | 722.30 K | $409.61 K | 0.08% | 1.17% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 556.14 K | $315.39 K | 0.00% | 0.90% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 531.57 K | $301.52 K | 4.33% | 0.86% |
SHAY CAPITAL LLC | 02/14/2025 | 225.26 K | $127.75 K | 144.17% | 0.36% |
FIDUCIARY TRUST CO | 02/14/2025 | 215.00 K | $121.93 K | 0.00% | 0.35% |
STATE STREET CORP | 02/14/2025 | 156.77 K | $88.91 K | 26.56% | 0.25% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 148.61 K | $84.28 K | -9.31% | 0.24% |
RBF CAPITAL, LLC | 02/14/2025 | 142.81 K | $80.99 K | 0.00% | 0.23% |
JANE STREET GROUP, LLC | 02/14/2025 | 78.19 K | $44.34 K | 537.19% | 0.13% |
SQUAREPOINT OPS LLC | 02/14/2025 | 64.10 K | $36.35 K | 129.52% | 0.10% |
NORTHERN TRUST CORP | 02/14/2025 | 62.48 K | $35.43 K | 55.10% | 0.10% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 54.48 K | $30.89 K | 983.08% | 0.09% |
DLK INVESTMENT MANAGEMENT, LLC | 01/16/2025 | 53.00 K | $30.06 K | -17.19% | 0.09% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 49.36 K | $27.99 K | -49.65% | 0.08% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 27.07 K | $15.35 K | -0.01% | 0.04% |
GROUND SWELL CAPITAL, LLC | 02/14/2025 | 25.42 K | $14.42 K | 100.00% | 0.04% |
FMR LLC | 02/13/2025 | 21.05 K | $11.94 K | -7.87% | 0.03% |
HIGHTOWER ADVISORS, LLC | 02/07/2025 | 15.52 K | $8.80 K | -5.23% | 0.03% |
HRT FINANCIAL LP | 02/14/2025 | 13.85 K | $7.00 K | 100.00% | 0.02% |
BARCLAYS PLC | 02/13/2025 | 13.15 K | $7.00 K | 0.00% | 0.02% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 10.50 K | $5.99 K | 100.00% | 0.02% |
VIRTU FINANCIAL LLC | 02/11/2025 | 10.29 K | $6.00 K | 100.00% | 0.02% |
ATRIA WEALTH SOLUTIONS, INC. | 01/31/2025 | 10.00 K | $5.67 K | 100.00% | 0.02% |
MAI CAPITAL MANAGEMENT | 02/14/2025 | 4.00 K | $2.27 K | 100.00% | 0.01% |
02/06/2025 | 2.37 K | $1.34 K | 100.00% | 0.00% | |
ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 1.77 K | $1.24 K | 0.00% | 0.00% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 422 | $239 | -0.71% | 0.00% |
JPMORGAN CHASE & CO | 02/12/2025 | 273 | $155 | 0.00% | 0.00% |
LRI INVESTMENTS, LLC | 02/14/2025 | 225 | $128 | 0.00% | 0.00% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 186 | $105 | 100.00% | 0.00% |
HARBOUR INVESTMENTS, INC. | 02/10/2025 | 60 | $34 | 0.00% | 0.00% |
FARTHER FINANCE ADVISORS, LLC | 02/10/2025 | 50 | $28 | 100.00% | 0.00% |
GROUP ONE TRADING, L.P. | 02/14/2025 | 47 | $27 | 0.00% | 0.00% |
UBS GROUP AG | 02/14/2025 | 2 | $1 | 100.00% | 0.00% |
FEDERATED HERMES, INC. | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
CITADEL ADVISORS LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
TWO SIGMA SECURITIES, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
ENGINEERS GATE MANAGER LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
Passage Bio, Inc. institutional Ownership - FAQ's
During the previous two years, 35 institutional investors and hedge funds held shares of Passage Bio, Inc.. The most heavily invested institutionals were:
Lynx1 Capital Management LP: 9.26 M
ORBIMED ADVISORS LLC: 7.03 M
Vestal Point Capital, LP: 6.1 M
TANG CAPITAL MANAGEMENT LLC: 1.5 M
ACADIAN ASSET MANAGEMENT LLC: 933,764
FIDUCIARY TRUST CO: 215,000
60.93% of Passage Bio, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 30.32 M shares in the last 24 months. This purchase volume represents approximately $9.10 M in transactions.